Peer-influenced content. Sources you trust. No registration required. This is HCN.
Verywell Health
Although limited research exists that spot reduction—the ability to target fat from a specific area—is possible, it is generally accepted that the best way to lose belly fat is through exercise and overall body fat loss.
Cardiology March 13th 2025
Cleveland Clinic Journal of Medicine (CCJM)
ARREST-AF offers very promising insight into the potential efficacy of complete risk-factor modification.
Cardiology March 11th 2025
Medical News Today (MNT)
“We are recommending that if patients are starting these drugs or increasing the dose of these drugs, they should do so slowly to reduce the risk of dropping their blood sugar and causing an osmotic shift.”
Endocrinology, Diabetes, Metabolism February 21st 2025
Women’s Healthcare
The study demonstrated a reduced risk of suicidal thoughts and self-harm among people using GLP-1 drugs.
Clinical Pharmacology February 11th 2025
Annals of Internal Medicine
In a systematic review of 26 randomized controlled trials involving over 15,000 participants, tirzepatide demonstrated weight reduction of 17.8% at 72 weeks, while newer agents like retatrutide achieved up to 22.1% reduction at 48 weeks, providing clinicians with expanded options for pharmacological weight management.
Endocrinology, Diabetes, Metabolism February 6th 2025
Research shows tirzepatide users achieve up to 25% body weight reduction, driving social media users to seek accessible alternatives through unproven natural remedies.